Integra LifeSciences
IART
Integra LifeSciences (IART) - Cash on Hand
Cash on Hand as of December 2023 : $0.30 B
According to Integra LifeSciences's latest financial reports the company has $0.30 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Integra LifeSciences - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.30 B | -32.31% |
| 2022-12-31 | $0.45 B | -11.06% |
| 2021-12-31 | $0.51 B | 9.21% |
| 2020-12-31 | $0.47 B | 136.37% |
| 2019-12-31 | $0.19 B | 43.27% |
| 2018-12-31 | $0.13 B | -20.63% |
| 2017-12-31 | $0.17 B | 71.41% |
| 2016-12-31 | $0.10 B | 112.03% |
| 2015-12-31 | $48.13 M | -32.9% |
| 2014-12-31 | $71.73 M | -40.53% |
| 2013-12-31 | $0.12 B | 24.42% |
| 2012-12-31 | $96.93 M | -3.84% |
| 2011-12-31 | $0.10 B | -21.71% |
| 2010-12-31 | $0.12 B | 79.11% |
| 2009-12-31 | $71.89 M | -60.83% |
| 2008-12-31 | $0.18 B | 220.11% |
| 2007-12-31 | $57.33 M | 152.63% |
| 2006-12-31 | $22.69 M | -82.16% |
| 2005-12-31 | $0.12 B | 26.19% |
| 2004-12-31 | $0.10 B | -7.13% |
| 2003-12-31 | $0.10 B | 9.8% |
| 2002-12-31 | $98.86 M | 48.22% |
| 2001-12-31 | $66.7 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 7,317.44% | 🇺🇸 USA |
 Medtronic MDT | $8.32 B | 2,592.04% | 🇮🇪 Ireland |
 Stryker Corporation SYK | $3.05 B | 887.72% | 🇺🇸 USA |
 Teleflex TFX | $0.22 B | -27.90% | 🇺🇸 USA |
 Cardinal Health CAH | $4.59 B | 1,385.30% | 🇺🇸 USA |
 Dentsply Sirona
XRAY | $0.33 B | 8.06% | 🇺🇸 USA |
 CONMED CNMD | $24.29 M | -92.14% | 🇺🇸 USA |